Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
NPJ Precision Oncology
|
June 17, 2026
Integration and validation of complementary ex vivo assays for functional precision oncology
Anna Loboda, Jasmina Paluncic, Micaela Freitas, et al.
Journal of the American Chemical Society
|
October 6, 2022
Aza-SAHA Derivatives Are Selective Histone Deacetylase 10 Chemical Probes That Inhibit Polyamine Deacetylation and Phenocopy HDAC10 Knockout
Raphael R Steimbach, Corey J Herbst-Gervasoni, Severin Lechner, et al.
Acta Neuropathologica
|
August 25, 2011
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat
Till Milde, Susanne Kleber, Andrey Korshunov, et al.
Cancer Research
|
January 15, 2014
GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3
Johannes Fabian, Marco Lodrini, Ina Oehme, et al.
Leukemia
|
April 29, 2025
The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cells
Andreas O Mieland, Giuseppe Petrosino, Mario Dejung, et al.
Oncotarget
|
December 22, 2016
Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing
Florian Selt, Juliane Hohloch, Thomas Hielscher, et al.
Scientific Reports
|
April 10, 2026
Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach
Julia K Sundheimer, Julia Benzel, Aniello Federico, et al.
Neuro-Oncology
|
August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma
Jonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Journal of Neuro-Oncology
|
May 14, 2023
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
Gintvile Valinciute, Jonas Ecker, Florian Selt, et al.
Cancers
|
February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models
Charlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
NPJ Precision Oncology
|
June 17, 2026
Integration and validation of complementary ex vivo assays for functional precision oncology
Anna Loboda, Jasmina Paluncic, Micaela Freitas, et al.
Journal of the American Chemical Society
|
October 6, 2022
Aza-SAHA Derivatives Are Selective Histone Deacetylase 10 Chemical Probes That Inhibit Polyamine Deacetylation and Phenocopy HDAC10 Knockout
Raphael R Steimbach, Corey J Herbst-Gervasoni, Severin Lechner, et al.
Acta Neuropathologica
|
August 25, 2011
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat
Till Milde, Susanne Kleber, Andrey Korshunov, et al.
Cancer Research
|
January 15, 2014
GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3
Johannes Fabian, Marco Lodrini, Ina Oehme, et al.
Leukemia
|
April 29, 2025
The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cells
Andreas O Mieland, Giuseppe Petrosino, Mario Dejung, et al.
Oncotarget
|
December 22, 2016
Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing
Florian Selt, Juliane Hohloch, Thomas Hielscher, et al.
Scientific Reports
|
April 10, 2026
Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach
Julia K Sundheimer, Julia Benzel, Aniello Federico, et al.
Neuro-Oncology
|
August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma
Jonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Journal of Neuro-Oncology
|
May 14, 2023
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
Gintvile Valinciute, Jonas Ecker, Florian Selt, et al.
Cancers
|
February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models
Charlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Page
of 9